People living with HIV/AIDS in Southwest Goiás: sociodemographic, clinical and laboratory characterization in the year 2018
DOI:
https://doi.org/10.11606/issn.1679-9836.v102i1e-195987Keywords:
HIV, Health profile, OutpatientsAbstract
Introduction: The number of people living with HIV (PLHIV) in Brazil is significant, and not restricted to large centers, which makes it necessary to understand the clinical and epidemiological characteristics of each region so that public policies can be established in a realistic, practical, and applicable way to the peculiarities of this disease. Objective: To characterize the sociodemographic, clinical, and laboratory profile of PLHIV who had their first consultation at an outpatient clinic in the city of Jataí, Goiás, in 2018. Methods: Sociodemographic, clinical, and laboratory data were collected from the medical records of a sample of 80 PLHIV attended at an outpatient clinic in Jataí, Goiás, in 2018. Data were analyzed using descriptive and inferential statistics. Results: There was a predominance of men (71.3%), aged 16-35 years (61.3%), single (68.8%), heterosexual (43.8%), employed (70.0%), and the route of exposure to HIV was through sexual intercourse (97.5%). Herpes zoster stood out as an opportunistic infection (27.8%), and syphilis (76.9%) as well as other infections and anxiety disorder (30.0%) as comorbidities. Men, compared to women, were positively associated with the diagnosis of other infections (p=0.0250) and with altered values for aspartate aminotransferase (p=0.0410). On the other hand, the PLHIV attended due to diagnosis, in relation to those due to transfer/abandonment, showed a positive association with the presence of detectable viral load (p=0.0001) and adequate abdominal circumference (p=0.0304). Conclusion: In 2018, consultations for newly diagnosed patients predominated, as well as for adults, men, single people, heterosexuals, and employed individuals. Herpes zoster and syphilis were the most common infections, the route of exposure to HIV was sexual intercourse, and men showed alterations in aspartate aminotransferase and a greater presence of other infections. Detectable viral load and adequate abdominal circumference were more present in newly diagnosed PLHIV.
Downloads
References
UNAIDS. Estatísticas. 2021. Disponível em: https://unaids.org.br/estatisticas
Brasil. Ministério da Saúde. Boletim Epidemiológico de HIV e Aids. Brasília: Ministério da Saúde; 2021. Disponível em: http://www.aids.gov.br/pt-br/pub/2021/boletim-epidemiologico-hivaids-2021
Goiás. Secretaria de Estado da Saúde de Goiás. Boletim epidemiológico HIV/Aids - 2019. Goiânia; 2019. Disponível em: https://www.saude.go.gov.br/boletins-informes
Kiragga AN, Mubiru F, Kambagu AD, Kamya MR, Castelnuovo B. A decade of antiretroviral therapy in Uganda: what are the emerging causes of death? BMC Infec Dis. 2019;19(1):e77. doi: http://dx.doi.org/10.1186/s12879-019-3724-x
Brasil. Ministério da Saúde. Protocolo Clínico e Diretrizes Terapêuticas para Manejo da Infecção pelo HIV em Adultos. Brasília: Ministério da Saúde; 2018. Disponível em: http://www.aids.gov.br/pt-br/pub/2013/protocolo-clinico-e-diretrizes-terapeuticas-para-manejo-da-infeccao-pelo-hiv-em-adultos
Cima M, Parker RD, Ahmed Y, Cook S, Dykema S, Dukes K, et al. Cause of death in HIV-infected patients in South Carolina (2005-2013). Int J STD AIDS. 2015;27:25-32. doi: http://dx.doi.org/10.1177/0956462415571970
Sanabria-Mazo JP, Hoyos-Hernandéz PA, Bravo F. Psychosocial factors associated with HIV testing in Colombian university students. Act Colom Psicol. 2020;23:158-168. doi: http://dx.doi.org/10.14718/acp.2020.23.1.8
Vieira JGS. Metodologia de pesquisa científica na prática. Curitiba: Fael; 2010. Disponível em: https://aedmoodle.ufpa.br/pluginfile.php/248784/mod_resource/content/1/LIVRO-Metodologia%20de%20Pesquisa%20Cient%C3%ADfica%20na%20pr%C3%A1tica.pdf
Sposito AC, Caramelli B, Fonseca FA, Bertolami MC, Afiune Neto A, Souza AD, et al.; Sociedade Brasileira de Cardiologia. IV Brazilian Guideline for Dyslipidemia and Atherosclerosis prevention: Department of Atherosclerosis of Brazilian Society of Cardiology. Arq Bras Cardiol. 2007;88(Suppl1):2-19. doi: http://dx.doi.org/10.1590/S0066-782X2007000700002
Faludi AA, Izar MCO, Saraiva JFK, Chacra APM, Bianco HT, Afiune Neto A, et al. Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017. Arq Bras Cardiol. 2017;109:1-76. doi: https://dx.doi.org/10.5935/abc.20170121
Segatto AFM, Freitas Junior IF, Santos VR, Alves KCP, Barbosa DA, Portelinha Filho AM, et al. Lipodytrophy in HIV/Aids patients with different levels of physical activity while on antiretroviral therapy. Rev Soc Bras Med Trop. 2011;44(4):420-424. doi: https://dx.doi.org/10.1590/S0037-86822011000400004
Ribeiro-Alves MA, Gordan PA, Sociedade Brasileira de Nefrologia. Diagnóstico de anemia em pacientes portadores de doença renal crônica. J Bras Nefrol. 2007;29:4-7. doi: http://dx.doi.org/10.5935/0101-2800.2014S003
Barbosa DA, Gunji CK, Bittencourt ARC, Belasco AGS, Diccini S, Vattimo F, et al. Co-morbidade e mortalidade de pacientes em início de diálise. Acta Paul Enferm. 2006;19(3):1-6. doi: http://dx.doi.org/10.1590/S0103-21002006000300008
Abensur H. E-book - Biomarcadores na Nefrologia. São Paulo: Associação Brasileira de Nefrologia; 2011. Disponível em: https://arquivos.sbn.org.br/pdf/biomarcadores.pdf
Sociedade Brasileira de Patologia Clínica. Medicina Laboratorial. Passo a passo para a implantação da estimativa da taxa de filtração glomerular (eTFG). 2a ed. São Paulo: Sociedade Brasileira de Patologia Clínica; 2015. Disponível em: http://www.sbpc.org.br/upload/conteudo/padronizacao_eTFG_4nov2015.pdf
Kirstajn GM, Salgado Filho N, Draibe SA, Pádua Netto MV, Thomé FS, Souza E, et al. Fast reading of the KDIGO 2012: Guidelines for evaluation and management of chronic kidney disease in clinical practice. J Bras Nefrol. 2014;36:63-73. doi: https://doi.org/10.5935/0101-2800.20140012
Scherzer R, Heymsfield SB, Lee D, Powderly WG, Tien PC, Bacchetti P, et al. Decreased limb muscle and increased central adiposity are associated with 5 year all cause mortality in HIV infection. AIDS. 2011;25(11):1405-1414. doi: http://dx.doi.org/10.1097/QAD.0b013e32834884e6
Brasil. Ministério da Saúde. Perfil da morbimortalidade masculina no Brasil. Brasília: Ministério da Saúde; 2018. Disponível em: https://portalarquivos2.saude.gov.br/images/pdf/2018/novembro/07/Perfil-da-morbimortalidade-masculina-no-Brasil.pdf
Menezes EG, Santos SRF, Melo, GZS, Torrente G, Pinto AS, Goiabeira YNLA. Factors associated with non-compliance with antiretrovirals in HIV/AIDS patients. Acta Paul Enferm. 2018;31:299-304. doi: https://doi.org/10.1590/1982-0194201800042
Foresto JS, Melo ES, Costa CRB, Antonini M, Gir E, Reis RK. Adherence to antiretroviral therapy by people living with HIV/AIDS in a municipality of São Paulo. Rev Gaúcha Enferm. 2017;38:e63158. doi: https://doi.org/10.1590/1983-1447.2017.01.63158
Goiás (Governo). Secretaria Estadual de Saúde. Boletim Epidemiológico HIV/Aids – 2019. Disponível em: http://www.mpgo.mp.br/portal/arquivos/2019/12/04/10_09_55_977_ses_go_boletimhivaids2019.pdf
Dias RFG, Bento LO, Tavares C, Ranes Filho H, Silva MAC, Moraes LC, et al. Epidemiological and clinical profile of HIV-infected patients from Southwestern Goias State, Brazil. Rev Inst Med Trop São Paulo. 2018;60(34):1-8. doi: https://dx.doi.org/10.1590/S1678-9946201860034
Arce F, Villanueva A. ¿Influye el sexo em el retrasode la vinculación al programa TARV em los pacientes com VIH? Rev Fac Med Hum. 2019;19(4):131-132. doi: http://dx.doi.org/10.25176/rfmh.v19i4.2196
Souza Júnior EV, Cruz DP, Caricchio GMN, Jesus MAS, Boery RNSO, Boery EN. Epidemiological aspects of morbimortality due human immunodeficiency virus in the brazilian northeast. Rev Fund Care Online. 2021;13:144-149. doi: 10.9789/2175-5361.rpcfo.v13.8025
Amaral RS, Carvalho STRF, Silva FMAM, Dias RS. Soropositividade para HIV/AIDS e características sociocomportamentais em adolescentes e adultos jovens. Rev Pesq Saúde. 2017;18(2):108-113. Disponível em: http://www.periodicoseletronicos.ufma.br/index.php/revistahuufma/article/viewFile/8384/5209
Chaves LL, Freitas CS, Costa GS, Lima MMMA, Martins MB, Marinho ICP, et al. Prevalência de infecções oportunistas em pacientes HIV positivos atendidos no Centro de Testagem e Aconselhamento (CTA) em município do Pará, em 2015 e 2016. REAS. 2020;51:e3554. doi: https://doi.org/10.25248/reas.e3554.2020
Oliveira FBM, Queiroz AAFLN, Sousa AFL, Moura MEB, Reis RK. Sexual orientation and quality of life of people living with HIV/Aids. Rev Bras Enferm. 2017;70(5):1004-1010. doi: https://doi.org/10.1590/0034-7167-2016-0420
Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med. 2008;70(5):539-545. doi: https://doi.org 10.1097/PSY.0b013e3181777a5f
Pimentel GS, Ceccato MGB, Costa JO, Mendes JC, Bonolo PF, Silveira MR. Quality of life in individuals initiating antiretroviral therapy: a cohort study. Rev Saúde Pública. 2020;54:e146. doi: https://doi.org/10.11606/s1518-8787.2020054001920
Brasil. Ministério da Saúde. Nota Informativa n.007/2017-DDAHV/SVS/MS, de 07 de fevereiro de 2017. Retificação da Nota Informativa n.096, de 2016/DDAHV/SVS/MS, que atualiza os esquemas antirretrovirais para pessoas vivendo com HIV/aids (PVHA) e indicações de uso ampliado de dolutegravir (DTG) e darunavir (DRV) a partir de 2017. Disponível em: http://www.aids.gov.br/pt-br/legislacao/nota-informativa-no-0072017-ddahv-svs-ms
Beraldo RA, Meliscki GC, Silva BR, Navarro AM, Bollela VR, Schmidt A, et al. Comparing the ability of anthropometric indicators in identifying metabolic syndrome in HIV patients. PLoS ONE. 2016;11(2):e0149905. doi: https://doi.org/10.1371/journal.pone.0149905
Guimarães NS, Caporali JFM, Reis PVCC, Tanajura, PR, Guimarães AR, Tupinambás U. Alterações metabólicas e estimativa de risco cardiovascular em pessoas vivendo com HIV/AIDS doze meses após o início da TARV. Rev Med Minas Gerais. 2017;27:e1859. doi: http://www.dx.doi.org/10.5935/2238-3182.20170054
Hussain I, Patni N, Garg A. Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease. Pathology. 2019;51(2):202-212. doi: https://doi.org/10.1016/j.pathol.2018.11.004
Raposo MA, Armiliato GNA, Guimarães NS, Caram CA, Silveira RDS, Tupinambas U. Metabolic disorders and cardiovascular risk in people living with HIV/aids without the use of antiretroviral therapy. Rev Soc Bras Med Trop. 2017;50(5):598-606. doi: https://doi.org/10.1590/0037-8682-0258-2017
Pokorska-Śpiewak M, Stańska-Perka A, Popielska J, Ołdakowska A, Coupland U, Zawadka K, et al. Prevalence and predictors of liver disease in HIV-infected children and adolescents. Sci Rep. 2017;7:e12309. doi: https://doi.org/10.1038/s41598-017-11489-2
Gouvêa, AFTB; Carvalho Filho, R; Machado, DM; Carmo, FB, Beltrão SV, Sampaio L, et al. Assessment of liver disease by non-invasive methods in perinatally infected Brazilian adolescents and young adults living with Human Immunodeficiency Virus (HIV). Braz J Infect Dis. 2021;25(3):e101589. doi: https://doi.org/10.1016/j.bjid.2021.101589
Squillace N, Ricci E, Menzaghi B, De Socio GV, Passerini S, Martinelli C, et al. The effect of switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) on liver enzymes, glucose, and lipid profile. Drug Des Devel Ther. 2020;15(14):5515-5520. doi: https://doi.org/10.2147/DDDT.S274307
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Ana Karla dos Santos Caixeta, Lillian Socorro Menezes de Souza, Eduardo Vignoto Fernandes, Regyane Ferreira Guimarães Dias, Hélio Ranes de Menezes Filho, Luiz Fernando Gouvêa-e-Silva
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
